Harmonic interplay of angiogenic growth factors in the development of coronary blood vessels.
Yokoyama
M
M
Hirase
T
T
D000818:Animals; D000831:Animals, Newborn; D000906:Antibodies / Q000494:pharmacology; D001160:Arterioles / Q000187:drug effects / Q000254:growth & development; D002196:Capillaries / Q000187:drug effects / Q000254:growth & development; D003331:Coronary Vessels / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism*; D016228:Endothelial Growth Factors / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000037:antagonists & inhibitors / Q000378:metabolism; D018390:Gene Targeting; D006133:Growth Substances / Q000378:metabolism*; D008222:Lymphokines / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D018919:Neovascularization, Physiologic / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000906:Antibodies; D016228:Endothelial Growth Factors; D006133:Growth Substances; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016222:Fibroblast Growth Factor 2